A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R
Phase of Trial: Phase IV
Latest Information Update: 04 Aug 2017
Price : $35 *
At a glance
- Drugs Azilsartan (Primary) ; Telmisartan
- Indications Essential hypertension; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Takeda
- 31 Aug 2018 Biomarkers information updated
- 26 Jul 2016 Status changed from active, no longer recruiting to completed.
- 07 Apr 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.